secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001808805-22-000059
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nautilus Biotechnology stockholders elect three Class I directors and ratify PwC as auditor
--------------------------------------------------------------------------------

- Sujal Patel, Vijay Pande, and Michael Altman elected as Class I directors with ~68.5M votes each.
- Broker non-votes of 11,840,796 shares on director election.
- Ratification of PricewaterhouseCoopers as independent auditor: 80.9M for, 31,871 against.
- 81,224,940 shares represented (65.3% of 124,456,653 outstanding shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000180880522000059/0001808805-22-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000180880522000059/naut-20220614.htm
  HTML page:      https://secwatch.observer/filing/0001808805-22-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer